Journal of Addiction and Preventive Medicine

Editor in Chief

Dr. Anand Mehendale is the Director of the Phoenix Addiction Research Institute at Clear Springs Ranch health care, Texas. He is the Chief Medical Officer of the Ranch at Clear Springs. He is the member of the American Society of Addiction Medicine, and the American Academy of Neurology. In the past he was, the President of Texas Society of Addiction Medicine. He is the Governing Board member of…

Name : Anand Mehendale
University : Phoenix Addiction Research Institute

Indexing and Listing

 

Recent Articles

PubMed Indexed Articles

  • article image

    Newborn Hearing Screenings in Human Immunodeficiency Virus- Exposed Uninfected Infants

    Perinatal HIV infection and congenital cytomegalovirus (CMV) infection may increase the risk for hearing loss. We examined 1,435 infants enrolled in the Surveillance Monitoring of ART Toxicities (SMARTT) study of the Pediatric HIV/AIDS Cohort Study (PHACS) network, a prospective study of the safety of in utero antiretroviral (ARV) exposures. We determined…

    View more
  • article image

    Health Literacy and Education Predict Nutrient Quality of Diet of Socioeconomically Diverse, Urban Adults

    Health literacy is defined as “the degree to which individuals have the capacity to obtain, process, and understand basic health information and services needed to make appropriate health decisions”. To be health literate, comprehensions as well as numeracy are needed. Health numeracy is defined as “the degree to which individuals have the capacity…

    View more
  • article image

    Optimization of a Clinically Relevant Model of White Matter Stroke in Mice: Histological and Functional Evidences

    White matter (WM) injury during stroke increases the risk of disability and gloomy prognosis of post-stroke rehabilitation. However, modeling of WM loss in rodents has proven to be challenging. We report improved WM injury models in male C57BL/6 mice. Mice were given either endothelin-1 (ET-1) or L-N5-(1-iminoethyl)ornitine (L-NIO) into the periventricular…

    View more

Testimonial